HOME › Research Insight › Immunohistochemistry and Breast Cancer Diagnostics are the New Revenue Pockets in the Tissue Diagnostics Market
Immunohistochemistry and Breast Cancer Diagnostics are the New Revenue Pockets in the Tissue Diagnostics Market
Tissue diagnostics tests are primarily used for screening, diagnosis, determining the prognosis, and monitoring the response to the therapy for cancer. The rising incidence of chronic diseases, aging population, and increasing healthcare spending are important growth drivers for the global tissue diagnostics market.
The technology segments included in this report are immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special staining. IHC is the most widely used technology in the tissue diagnostics market, and is also expected to grow at the highest rate amongst all technology segments in this market. In fact, the estimated market size of IHC in 2018 is expected to be larger than the combined market size of the other three technology segments in that year. IHC enables the diagnosis of cancer tissues by identification of the aberrant tissue morphology using tagged antibodies. The ease of use of IHC and its cost advantages over other techniques like ISH makes it the most widely used technology in this market. Furthermore, the use of IHC products as companion diagnostics in personalized medicine also adds to its share in this market.
The disease segments included in this report are breast cancer, gastric cancer, lymphoma, prostate cancer, non-small-cell lung cancer (NSCLC), and other disease segments. The breast cancer disease segment commanded the largest share of the global tissue diagnostics market in 2013 and is also poised to grow at the highest CAGR between 2013 and 2018. Breast cancer is the most common form of cancer in women. Nearly 1.7 million new breast cancer cases were diagnosed in 2012. This accounted for 12% of all new cancer cases and 25% of all cancers in women in that year. Alcohol consumption has been linked to post-menopausal breast cancer in women. Lifestyle changes and a rapidly aging population have compounded the effect and have lead to increasing incidences of cancer.
Hence, IHC and breast cancer diagnostics will be important revenue pockets in the global tissue diagnostics market in the forecast period between 2013 and 2018.
Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252